Genomic Test May Reveal Which Prostate Cancer Patients Gain Most From Hormone Therapy
An NRG Oncology SPPORT trial analysis found that Luminal B prostate tumors identified by the PAM50 genomic classifier predicted a ...
Tag: SPPORT trial
POPULAR NEWS
-
Alloys That Shrink Their Own Grains: New PIX Mechanism Refines Metals With Heat Alone
-
Endurance Exercise Reshapes the Liver in Males and Females Through Distinct Molecular Routes
-
Single Transcription Factor PU.1 Rapidly Converts Fibroblasts into Macrophage-Lineage Cells
-
New Scale Measures How Ready Nurse Educators Really Are for the AI Era